TNFRSF10C and Bardet-Biedl syndrome: Both BBS and AS lack clear genotype-phenotype correlations, thus further in vivo studies are required to assess the safety and systemic efficacy of TRID treatment on a range of phenotypes associated with both ciliopathies prior to translation to clinical trials.